IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC) | Journal for ImmunoTherapy of Cancer
Proposal for a Standardized PSA Doubling-time Calculation | Anticancer Research
Salvage Radiation Therapy Nomograms | Dan's Journey through Prostate Cancer
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - ScienceDirect
![Tomography | Free Full-Text | [18F]fluciclovine vs. [18F]fluorocholine Positron Emission Tomography/Computed Tomography: A Head-to-Head Comparison for Early Detection of Biochemical Recurrence in Prostate Cancer Patients](https://www.mdpi.com/tomography/tomography-08-00226/article_deploy/html/images/tomography-08-00226-g001-550.jpg "Tomography | Free Full-Text | [18F]fluciclovine vs. [18F]fluorocholine Positron Emission Tomography/Computed Tomography: A Head-to-Head Comparison for Early Detection of Biochemical Recurrence in Prostate Cancer Patients")
Tomography | Free Full-Text | [18F]fluciclovine vs. [18F]fluorocholine Positron Emission Tomography/Computed Tomography: A Head-to-Head Comparison for Early Detection of Biochemical Recurrence in Prostate Cancer Patients
A non–conformity approach towards post-prostatectomy metastasis estimation using a multicenter prostate cancer database
Prostate Cancer Prediction Tools — Metrovan Urology
GitHub - conan-koh123/Calculating-PSA-Doubling-Time-for-many-patients: R code to calculate PSA doubling time (in months) for many patients
Prostate-specific antigen doubling time as a prognostic marker in prostate cancer | Nature Reviews Urology
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Prostate Cancer Nomograms: PSA Doubling Time | Memorial Sloan Kettering Cancer Center
Prostate Cancer Nomograms: PSA Doubling Time | Memorial Sloan Kettering Cancer Center
Low detectable PSA after prostatectomy – watch or treat? | THE "NEW" PROSTATE CANCER INFOLINK
Role of Local and/or Metastasis-directed Therapy in Patients with Hormone-sensitive M1a Prostate Cancer—A Systematic Review - European Urology Oncology
Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time | BMC Urology | Full Text
Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer | Scientific Reports
PDF) Prostate Cancer-Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
PDF) Comparison of Different Machine Learning Models in Prediction of Postirradiation Recurrence in Prostate Carcinoma Patients
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - ScienceDirect
Prostate-specific antigen doubling time as a prognostic marker in prostate cancer | Nature Reviews Urology
